{"organizations": [], "uuid": "90c8e8ba37dbcdc391eef0d3875534e268ae3128", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-the-ema-grants-accelerated-assessm/brief-the-ema-grants-accelerated-assessment-for-shires-lanadelumab-idUSFWN1QH19O", "country": "US", "domain_rank": 408, "title": "BRIEF-The EMA Grants Accelerated Assessment For Shire's Lanadelumab", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.503, "site_type": "news", "published": "2018-02-28T00:34:00.000+02:00", "replies_count": 0, "uuid": "90c8e8ba37dbcdc391eef0d3875534e268ae3128"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-the-ema-grants-accelerated-assessm/brief-the-ema-grants-accelerated-assessment-for-shires-lanadelumab-idUSFWN1QH19O", "ord_in_thread": 0, "title": "BRIEF-The EMA Grants Accelerated Assessment For Shire's Lanadelumab", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "shire plc", "sentiment": "negative"}, {"name": "shire", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eu", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Shire Plc:\n* THE EMA GRANTS ACCELERATED ASSESSMENT FOR SHIRE‘S LANADELUMAB BEING EVALUATED FOR THE PREVENTION OF ATTACKS IN HAE PATIENTS AGED 12 YEARS AND OLDER\n* SAYS IS ON TRACK TO SUBMIT EU MARKETING AUTHORIZATION APPLICATION FOR SHP643 IN COMING WEEKS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T00:34:00.000+02:00", "crawled": "2018-02-28T13:21:24.000+02:00", "highlightTitle": ""}